FDA's approval of Biogen Alzheimer's drug slammed in report
U.S. health officials' approval process for Biogen Inc.'s controversial Alzheimer's drug was "rife with irregularities," raising serious concerns about protocol lapses at the agenc…
U.S. health officials' approval process for Biogen Inc.'s controversial Alzheimer's drug was "rife with irregularities," raising serious concerns about protocol lapses at the agenc…